Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
So Yoon Sim
Observed names:
S.Y. Sim,
Sim, So Yoon
Institution:
World Health Organization
Observed institutions:
Johns Hopkins University,
City University of New York,
London School of Hygiene & Tropical Medicine,
World Health Organization
ORCID:
0000-0002-3267-1867
Observed ORCID:
0000-0002-3267-1867
OpenAlex ID:
A5001002212
Contribution of vaccination to improved survival and health: modelling 50 years of the Expanded Programme on Immunization
2024
·
Andrew J Shattock
, Helen C Johnson
, et al.
·
The Lancet
·
640
Return On Investment From Immunization Against 10 Pathogens In 94 Low- And Middle-Income Countries, 2011–30
2020
·
So Yoon Sim
, Elizabeth Watts
, et al.
·
Health Affairs
·
140
Modeling the impact of vaccination for the immunization Agenda 2030: Deaths averted due to vaccination against 14 pathogens in 194 countries from 2021 to 2030
2023
·
Austin Carter
, William Msemburi
, et al.
·
Vaccine
·
117
The Full Value of Vaccine Assessments (FVVA): a framework for assessing and communicating the value of vaccines for investment and introduction decision-making
2023
·
Raymond Hutubessy
, Jeremy A. Lauer
, et al.
·
BMC Medicine
·
68
PDF
The cost and cost-effectiveness of novel tuberculosis vaccines in low- and middle-income countries: A modeling study
2023
·
Allison Portnoy
, Rebecca A. Clark
, et al.
·
PLoS Medicine
·
49
PDF
Economic Benefits of Immunization for 10 Pathogens in 94 Low- and Middle-Income Countries From 2011 to 2030 Using Cost-of-Illness and Value-of-Statistical-Life Approaches
2020
·
Elizabeth Watts
, So Yoon Sim
, et al.
·
Value in Health
·
45
Modeling the Impact of Vaccination for the Immunization Agenda 2030: Deaths Averted Due to Vaccination Against 14 Pathogens in 194 Countries from 2021-2030
2021
·
Austin Carter
, William Msemburi
, et al.
·
SSRN Electronic Journal
·
41
Costs of Immunization Programs for 10 Vaccines in 94 Low- and Middle-Income Countries From 2011 to 2030
2020
·
So Yoon Sim
, Elizabeth Watts
, et al.
·
Value in Health
·
30
Estimating the health effects of COVID-19-related immunisation disruptions in 112 countries during 2020–30: a modelling study
2024
·
Anna-Maria Hartner
, Xiang Li
, et al.
·
The Lancet Global Health
·
27
PDF
The Full Value of Vaccine Assessments (FVVA): A Framework to Assess and Communicate the Value of Vaccines for Investment and Introduction Decision Making
2021
·
Raymond C.W. Hutubessy
, Jeremy Addison Lauer
, et al.
·
SSRN Electronic Journal
·
22
Cost of Nine Pediatric Infectious Illnesses in Low- and Middle-Income Countries: A Systematic Review of Cost-of-Illness Studies
2020
·
Gatien de Broucker
, So Yoon Sim
, et al.
·
PharmacoEconomics
·
21
PDF
A Scoping Review of Investment Cases for Vaccines and Immunization Programs
2019
·
So Yoon Sim
, Mark Jit
, et al.
·
Value in Health
·
19
Financing And Funding Gap For 16 Vaccines Across 94 Low- And Middle-Income Countries, 2011–30
2023
·
Salin Sriudomporn
, So Yoon Sim
, et al.
·
Health Affairs
·
13
Estimating the Impact of Vaccination Campaigns on Measles Transmission in Somalia
2024
·
Niket Thakkar
, Ali Haji Adam Abubakar
, et al.
·
Vaccines
·
11
PDF
Framework to guide the use of mathematical modelling in evidence-based policy decision-making
2025
·
Jacquie Oliwa
, Fatuma Hassan Guleid
, et al.
·
BMJ Open
·
10
Lessons learned from COVID-19 modelling efforts for policy decision-making in lower- and middle-income countries
2024
·
Collins J Owek
, Fatuma Guleid
, et al.
·
BMJ Global Health
·
9
PDF
A Practical Guide to Full Value of Vaccine Assessments
2024
·
Caroline Trotter
, Birgitte Giersing
, et al.
·
Vaccines
·
8
PDF
Quantifying relative health impact across Gavi, the Vaccine Alliance's portfolio in 117 countries at the subregional level: a modelling study
2026
·
Katy A M Gaythorpe
, Xiang Li
, et al.
·
The Lancet
·
4
Informing the development of transmission modelling guidance for global immunization decision-making: A qualitative needs assessment
2025
·
Julie Leask
, Maria Christou-Ergos
, et al.
·
Vaccine
·
4
Achieving immunization agenda 2030 coverage targets for 14 pathogens: Projected product and immunization delivery costs for 194 Countries, 2021–2030
2022
·
Salin Sriudomporn
, Elizabeth Watts
, et al.
·
Vaccine X
·
4
Health and economic impact of hepatitis B vaccination in the national immunization program in Belarus, Georgia, Kyrgyzstan, Republic of Moldova, Turkmenistan and Uzbekistan—a modelling study
2025
·
Maryam Sadeghimehr
, Liudmila Mosina
, et al.
·
Frontiers in Public Health
·
2
PDF
Health and Economic Impact of Hepatitis B Vaccination in Belarus, Georgia, Kyrgyzstan, Republic of Moldova, Turkmenistan and Uzbekistan- a Modelling Study
2024
·
Maryam Sadeghimehr
, Liudmila Mosina
, et al.
·
SSRN Electronic Journal
·
2
The Potential Economic Value of a Zika Vaccine for a Woman of Childbearing Age
2020
·
Sarah M. Bartsch
, Lindsey Asti
, et al.
·
American Journal of Preventive Medicine
·
2
Economic evaluation of combination vaccines: Enabling a more comprehensive assessment of their benefits and challenges
2026
·
Frédéric Debellut
, Dagna Constenla
, et al.
·
Vaccine
·
1
Standardized country-level delivery unit cost estimates for routine childhood, routine adolescent, and campaign vaccination: an updated modeling analysis
2026
·
Allison Portnoy
, Emma Clarke-Deelder
, et al.
·
medRxiv
·
1
PDF
Show more works
View as search
Works count:
45
Citation count:
1,296
H-index:
13
I10-index:
15
Year
Topic
Type
